BLOOD PRODUCTS

Brand Owner (click to sort) Address Description
BIOPLASMA CSL Limited 45 Poplar Road Parkville, Victoria 3052 Australia blood products, namely, plasma volume expanders, human albumin, blood clotting factors and immunoglobulins for medical and clinical use; pharmaceutical preparations derived from plasma and recombinant DNA technology for the prevention and/or treatment of blood disorders; products derived from recombinant DNA technology, namely, plasma volume expanders; human albumin, blood clotting factors, and immunoglobulins for medical or clinical use;BIO PLASMA;
BIOSTATE CSL Limited 45 Poplar Road Parkville, Victoria 3052 Australia Blood products, namely, human coagulation Factor VIII, human von Willebrand factor complex, and blood proteins for use in the treatment and/or prevention of blood and/or bleeding disorders, namely, haemophilia and von Willebrand disease;BIO STATE;
DEFACTO KABI PHARMACIA AB S-751 82 UPPSALA Sweden blood products; namely, anti hemophilic factor (recombinant factor-VIII) for the treatment of hemophilia A;
DOXOSOMES Cellphire, Inc. 9430 Key West Avenue Rockville MD 20850 Blood products, namely, compositions containing tumor treatment agents and freeze-dried platelets or rehydrated freeze-dried platelets for treatment of tumors;
HEMGADE CSL BEHRING GMBH Emil-von-Behring Str. 76 Marburg D-35041 Germany Blood products, namely, fibrinogen concentrate and blood clotting factors, all for human medicine;
INTRAGAM CSL Limited 45 Poplar Road Parkville, Victoria 3052 Australia BLOOD PRODUCTS, NAMELY, PLASMA VOLUME EXPANDERS, HUMAN ALBUMIN, BLOOD CLOTTING FACTORS AND IMMUNOGLOBULINS FOR MEDICAL AND CLINICAL USE; PHARMACEUTICAL PREPARATIONS DERIVED FROM PLASMA AND RECOMBINANT DNA TECHNOLOGY FOR THE PREVENTION AND/OR TREATMENT OF BLOOD DISORDERS, AUTO-IMMUNE DISORDERS, AND IMMUNE DEFICIENCIES; PRODUCTS DERIVED FROM RECOMBINANT DNA TECHNOLOGY, NAMELY, PLASMA VOLUME EXPANDERS; HUMAN ALBUMIN, BLOOD CLOTTING FACTORS, AND IMMUNOGLOBULINS FOR MEDICAL AND CLINICAL USE;
MEGAKARYON Megakaryon Corporation 93, Chudoji Awata-cho Shimogyo-ku, Kyoto-shi Kyoto 600-8815 Japan Blood products, namely, red blood cells, white blood cells, blood plasma, and platelets for medical purposes; blood for medical purposes; hemotropic agents, namely, anticoagulants, blood substitutes for human use and hemostatics for medical purposes;Testing, inspection and research services in the field of pharmaceuticals; testing, inspection and research services in the field of methods and technologies of medical treatment; research and development services in the field of cytology; blood analysis services; research and development services in the field of blood products, blood for medical purposes and hemotropic agents;
QAB BLOOD Daxor Corporation 350 Fifth Avenue, Suite 7120 New York NY 10118 blood products, namely, blood plasma, red blood cells, blood platelets and cryoprecipitate;BLOOD;
RIASTAP CSL BEHRING GMBH Emil-von-Behring Str. 76 Marburg D-35041 Germany Blood products, namely, fibrinogen concentrate for human medicine;The mark RIASTAP has no meaning in a foreign language.;
THE LEADER IN CORD BLOOD BANKING SERVICE Viacord, Inc. 551 Boylston Street Boston MA 02116 blood products, namely, cord blood and peripheral blood stem and progenitor cells;
THE LEADING PROVIDER IN CORD BLOOD BANKING SERVICE Viacord, Inc. 551 Boylston Street Boston MA 02116 blood products,namely, cord blood and peripheral blood stem and progenitor cells;
VIACORD VIACORD 245 FIRST STREET CAMBRIDGE MA 02142 blood products, namely cord blood and peripheral blood stem and progenitor cells;
 

Where the owner name is not linked, that owner no longer owns the brand

    
Technical Examples
  1. An extracorpeal blood circuit for removal of contrast from human blood using a filter and withdrawal filter pump and a by-pass pump. The withdrawal filter blood pump operates when a contrast bolus has been detected. Otherwise the bypass blood pump maintains physiological blood flow from the coronary sinus preventing the need for deflation and re-inflation of the balloon catheter. When contrast is detected blood the bypass blood pump is stopped to prevent contrast from leaking back into the patients circulatory system via the bypass pump and CS blood flow is maintained at its physiological blood flow resulting in the heart being oblivious to the transition by the prefilter blood pump.